Publication:
Serum IL-17A in Behcet-s disease

Placeholder

Organizational Units

Program

Authors

Emiroglu, NAZAN
Cengiz, FATMA PELİN
ERDEM, Gul Bahar

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Introduction: Behcet-s disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet-s disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.

Description

Source:

Keywords:

Citation

Emiroglu N., Cengiz F. P. , ERDEM G. B. , -Serum IL-17A in Behcet-s disease-, POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, ss.358-361, 2015

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals